| Both sides previous revision Previous revision Next revision | Previous revision |
| eyelash_poliosis [2026/05/26 19:09] – Scott Larson | eyelash_poliosis [2026/05/26 19:12] (current) – [Eyelash Poliosis] Scott Larson |
|---|
| ====== Eyelash Poliosis ====== | ====== Eyelash Poliosis ====== |
| FIXME | |
| |
| ====Causes==== | ====Causes==== |
| ====Resources==== | ====Resources==== |
| - [[https://pubmed.ncbi.nlm.nih.gov/21839315|Vitiligo: A Comprehensive Overview Part I. Introduction, Epidemiology, Quality of Life, Diagnosis, Differential Diagnosis, Associations, Histopathology, Etiology, and Work-Up. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V.Journal of the American Academy of Dermatology. 2011;65(3):473-491.]] | - [[https://pubmed.ncbi.nlm.nih.gov/21839315|Vitiligo: A Comprehensive Overview Part I. Introduction, Epidemiology, Quality of Life, Diagnosis, Differential Diagnosis, Associations, Histopathology, Etiology, and Work-Up. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V.Journal of the American Academy of Dermatology. 2011;65(3):473-491.]] |
| - [[ |Atopic Dermatitis.Ständer S. The New England Journal of Medicine. 2021;384(12):1136-1143. doi:10.1056/NEJMra2023911.]] | - [[https://www.nejm.org/doi/full/10.1056/NEJMra2023911|Atopic Dermatitis.Ständer S. The New England Journal of Medicine. 2021;384(12):1136-1143.]] |
| - [[|Topical Prostaglandin F(2alpha) Analog Induced Poliosis. Chen CS, Wells J, Craig JE. American Journal of Ophthalmology. 2004;137(5):965-6. doi:10.1016/j.ajo.2003.11.020.]] | - [[https://pubmed.ncbi.nlm.nih.gov/15126178/|Topical Prostaglandin F(2alpha) Analog Induced Poliosis. Chen CS, Wells J, Craig JE. American Journal of Ophthalmology. 2004;137(5):965-6.]] |
| - [[|Poliosis Circumscripta: Overview and Underlying Causes. Sleiman R, Kurban M, Succaria F, Abbas O. Journal of the American Academy of Dermatology. 2013;69(4):625-33. doi:10.1016/j.jaad.2013.05.022.]] | - [[https://pubmed.ncbi.nlm.nih.gov/23850259/|Poliosis Circumscripta: Overview and Underlying Causes. Sleiman R, Kurban M, Succaria F, Abbas O. Journal of the American Academy of Dermatology. 2013;69(4):625-33.]] |
| - [[ |Precise, Simplified Diagnostic Criteria and Optimised Management of Initial-Onset Vogt-Koyanagi-Harada Disease: An Updated Review. Herbort CP, Tugal-Tutkun I, Abu-El-Asrar A, et al. | - [[https://pubmed.ncbi.nlm.nih.gov/34145419/|Precise, Simplified Diagnostic Criteria and Optimised Management of Initial-Onset Vogt-Koyanagi-Harada Disease: An Updated Review. Herbort CP, Tugal-Tutkun I, Abu-El-Asrar A, et al. Eye (London, England). 2022;36(1):29-43.]] |
| Eye (London, England). 2022;36(1):29-43. doi:10.1038/s41433-021-01573-3.]] | |
| - [[https://pubmed.ncbi.nlm.nih.gov/34494974/|Recent Advances in Diagnosis and Management of Sympathetic Ophthalmia. Fromal OV, Swaminathan V, Soares RR, Ho AC. Current Opinion in Ophthalmology. 2021;32(6):555-560.]] | - [[https://pubmed.ncbi.nlm.nih.gov/34494974/|Recent Advances in Diagnosis and Management of Sympathetic Ophthalmia. Fromal OV, Swaminathan V, Soares RR, Ho AC. Current Opinion in Ophthalmology. 2021;32(6):555-560.]] |
| - [[https://pubmed.ncbi.nlm.nih.gov/30392755/|Guidelines of Care for the Management of Primary Cutaneous Melanoma. Swetter SM, et al. Journal of the American Academy of Dermatology. 2019;80(1):208-250.]] | - [[https://pubmed.ncbi.nlm.nih.gov/30392755/|Guidelines of Care for the Management of Primary Cutaneous Melanoma. Swetter SM, et al. Journal of the American Academy of Dermatology. 2019;80(1):208-250.]] |
| |
| {{tag>ddx}} | {{tag>ddx}} |